CN100379436C - 一种治疗抑郁症的药物组合物及其制备方法和应用 - Google Patents
一种治疗抑郁症的药物组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN100379436C CN100379436C CNB2006100020212A CN200610002021A CN100379436C CN 100379436 C CN100379436 C CN 100379436C CN B2006100020212 A CNB2006100020212 A CN B2006100020212A CN 200610002021 A CN200610002021 A CN 200610002021A CN 100379436 C CN100379436 C CN 100379436C
- Authority
- CN
- China
- Prior art keywords
- shares
- radix
- medicine
- parts
- depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 239000008194 pharmaceutical composition Substances 0.000 title claims description 20
- 239000003814 drug Substances 0.000 claims abstract description 44
- 239000000203 mixture Substances 0.000 claims abstract description 34
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000008187 granular material Substances 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 7
- 239000003826 tablet Substances 0.000 claims abstract description 5
- 239000002775 capsule Substances 0.000 claims abstract description 3
- 239000007788 liquid Substances 0.000 claims abstract description 3
- 239000006187 pill Substances 0.000 claims abstract description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 32
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 13
- 239000000341 volatile oil Substances 0.000 claims description 13
- 208000020401 Depressive disease Diseases 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 7
- 238000004064 recycling Methods 0.000 claims description 7
- 238000001256 steam distillation Methods 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- 239000012141 concentrate Substances 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 235000011438 Albizia odoratissima Nutrition 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 241000208966 Polygala Species 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000000890 drug combination Substances 0.000 claims description 2
- 238000002481 ethanol extraction Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims description 2
- 239000012567 medical material Substances 0.000 claims description 2
- 238000003809 water extraction Methods 0.000 claims description 2
- 241000220433 Albizia Species 0.000 claims 1
- 244000001632 Acorus gramineus Species 0.000 abstract 2
- 235000013073 Acorus gramineus Nutrition 0.000 abstract 2
- 240000007185 Albizia julibrissin Species 0.000 abstract 2
- 235000011468 Albizia julibrissin Nutrition 0.000 abstract 2
- 244000061520 Angelica archangelica Species 0.000 abstract 2
- 241000202726 Bupleurum Species 0.000 abstract 2
- 241000146384 Glaux Species 0.000 abstract 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 2
- 244000236658 Paeonia lactiflora Species 0.000 abstract 2
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 2
- 244000197580 Poria cocos Species 0.000 abstract 2
- 235000008599 Poria cocos Nutrition 0.000 abstract 2
- 239000002131 composite material Substances 0.000 abstract 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 23
- 241000699670 Mus sp. Species 0.000 description 11
- 239000000935 antidepressant agent Substances 0.000 description 10
- 210000004556 brain Anatomy 0.000 description 10
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 description 9
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 description 9
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 description 9
- 230000006399 behavior Effects 0.000 description 9
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 description 9
- 229960003147 reserpine Drugs 0.000 description 9
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 description 9
- 230000001430 anti-depressive effect Effects 0.000 description 8
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 7
- 229940005513 antidepressants Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000006698 induction Effects 0.000 description 6
- 229960002748 norepinephrine Drugs 0.000 description 6
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 6
- 241000581650 Ivesia Species 0.000 description 5
- 102000010909 Monoamine Oxidase Human genes 0.000 description 5
- 108010062431 Monoamine oxidase Proteins 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- LDCYZAJDBXYCGN-VIFPVBQESA-N 5-hydroxy-L-tryptophan Chemical compound C1=C(O)C=C2C(C[C@H](N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-VIFPVBQESA-N 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 description 3
- 206010010144 Completed suicide Diseases 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000008485 antagonism Effects 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000008451 emotion Effects 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000002858 neurotransmitter agent Substances 0.000 description 3
- 229960002296 paroxetine Drugs 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 238000001291 vacuum drying Methods 0.000 description 3
- 240000000559 Albizia odoratissima Species 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 208000008238 Muscle Spasticity Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 208000018198 spasticity Diseases 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 102000056834 5-HT2 Serotonin Receptors Human genes 0.000 description 1
- 108091005479 5-HT2 receptors Proteins 0.000 description 1
- 229940000681 5-hydroxytryptophan Drugs 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000218236 Cannabis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000207840 Jasminum Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 208000022120 Jeavons syndrome Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 229940121991 Serotonin and norepinephrine reuptake inhibitor Drugs 0.000 description 1
- 229940123445 Tricyclic antidepressant Drugs 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000003130 cardiopathic effect Effects 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000007368 endocrine function Effects 0.000 description 1
- 201000003104 endogenous depression Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 208000024714 major depressive disease Diseases 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000007935 oral tablet Substances 0.000 description 1
- 229940096978 oral tablet Drugs 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 229940053544 other antidepressants in atc Drugs 0.000 description 1
- LDCYZAJDBXYCGN-UHFFFAOYSA-N oxitriptan Natural products C1=C(O)C=C2C(CC(N)C(O)=O)=CNC2=C1 LDCYZAJDBXYCGN-UHFFFAOYSA-N 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 210000003800 pharynx Anatomy 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940023488 pill Drugs 0.000 description 1
- 230000007015 preclinical effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 229940124834 selective serotonin reuptake inhibitor Drugs 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 239000003029 tricyclic antidepressant agent Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 剂量(g/kg) | 例数 | 悬尾不动时间(秒) |
对照组药物组合物帕罗西汀 | -918363.3×10<sup>-3</sup> | 1411141213 | 107.14±49.4332.18±33.75<sup>**</sup>68.07±38.55<sup>*</sup>46.17±37.44<sup>**</sup>68.54±31.26<sup>*</sup> |
组别 | 剂量(g/kg) | 例数 | 甩头次数 | 甩头潜伏期(秒) |
对照组药物组合物帕罗西汀 | -918363.3×10<sup>-3</sup> | 1212121212 | 6.58±4.926.25±5.909.25±6.6312.00±8.7937.83±8.72<sup>**</sup> | 556.5±379.5476.1±259.0370.1±236.8373.5±191.1145.7±47.8<sup>**</sup> |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100020212A CN100379436C (zh) | 2006-01-23 | 2006-01-23 | 一种治疗抑郁症的药物组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100020212A CN100379436C (zh) | 2006-01-23 | 2006-01-23 | 一种治疗抑郁症的药物组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1840043A CN1840043A (zh) | 2006-10-04 |
CN100379436C true CN100379436C (zh) | 2008-04-09 |
Family
ID=37029346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100020212A Expired - Fee Related CN100379436C (zh) | 2006-01-23 | 2006-01-23 | 一种治疗抑郁症的药物组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100379436C (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101194982B (zh) * | 2006-12-07 | 2010-05-19 | 首都医科大学宣武医院 | 一种抗抑郁的中药组合物及其制备方法 |
CN101204575B (zh) * | 2007-12-20 | 2010-06-02 | 董建国 | 一种治疗抑郁性神经症的中药组合物及其制备方法和应用 |
CN101670075B (zh) * | 2009-10-16 | 2011-04-27 | 蚌埠丰原涂山制药有限公司 | 一种用于治疗抑郁症的中药组合物 |
CN103212019B (zh) * | 2012-12-10 | 2014-10-22 | 宋爱民 | 治疗抑郁症的中药制剂 |
CN107224498A (zh) * | 2016-12-13 | 2017-10-03 | 华北理工大学 | 治疗抑郁症的药物 |
CN112043807B (zh) * | 2020-09-03 | 2022-05-24 | 中国人民解放军63919部队 | 一种抗抑郁中药复方 |
CN113679779A (zh) * | 2021-09-18 | 2021-11-23 | 黑龙江省济仁药业有限公司 | 一种具有抗抑郁功效的中药组合物及其制备方法和应用 |
CN116370583A (zh) * | 2021-12-24 | 2023-07-04 | 四川大学华西医院 | 一种抗抑郁症的中药组合物及其制备方法和应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1308959A (zh) * | 2001-01-12 | 2001-08-22 | 王东桥 | 一种治疗神志病(精神病等)的药物-怡神解郁方剂 |
-
2006
- 2006-01-23 CN CNB2006100020212A patent/CN100379436C/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1308959A (zh) * | 2001-01-12 | 2001-08-22 | 王东桥 | 一种治疗神志病(精神病等)的药物-怡神解郁方剂 |
Non-Patent Citations (3)
Title |
---|
中医药治疗慢性疲劳综合征的现状与展望. 王海萍等.江苏中医药,第26卷第7期. 2005 * |
中药成方制剂第九册. 186. 1994 * |
浅谈卒中后抑郁症的病机与治疗. 李衍滨等.广西中医药,第22卷第6期. 1999 * |
Also Published As
Publication number | Publication date |
---|---|
CN1840043A (zh) | 2006-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100379436C (zh) | 一种治疗抑郁症的药物组合物及其制备方法和应用 | |
CN101254247B (zh) | 一种具有抗抑郁、抗焦虑作用的药物组合物及其制备方法 | |
CN1994451B (zh) | 治疗抑郁症的中药组合物及其制备方法和其应用 | |
CN101011561B (zh) | 黄连温胆汤现代中药口服制剂及其生产方法 | |
CN101357136B (zh) | 用于防治脑缺血损伤相关疾病的中药有效成分的组合物 | |
CN100522212C (zh) | 一种治疗抑郁症的中药组合物及其制备方法 | |
WO2013071727A1 (zh) | 抗肿瘤的中药组合物 | |
Wu et al. | Gastrodia elata BI.: A comprehensive review of its traditional use, botany, phytochemistry, pharmacology, and pharmacokinetics | |
KR20100106324A (ko) | 대추의 cAMP에 의해 제조되는 우울제 | |
CN101288761B (zh) | 一种治疗抑郁症的中药制剂及其制备方法 | |
CN1263503C (zh) | 菖远胶囊及其制备工艺 | |
CN1931276B (zh) | 一种治疗头痛的中药组合物及其制备方法 | |
CN101049435B (zh) | 一种预防中、老年人痴呆营养品的制造方法 | |
CN109172608B (zh) | 一种能改善睡眠质量的中药组合物 | |
CN101129492B (zh) | 一种治疗抑郁症的中药制剂 | |
CN105616839B (zh) | 一种具有抗抑郁作用的中药药效组分复方 | |
WO2009070922A1 (fr) | Compositions pharmaceutiques pour le traitement de l'anxiété | |
CN1104912A (zh) | 一种补肾壮阳口服液及生产方法 | |
CN101658573A (zh) | 治疗抑郁症的中药制剂 | |
CN115252753A (zh) | 治疗失眠的中药组合物及其应用 | |
CN101194982B (zh) | 一种抗抑郁的中药组合物及其制备方法 | |
CN101816708B (zh) | 治疗风湿病的中药组合物及其制备方法 | |
CN104435298A (zh) | 一种抗抑郁药物组合物 | |
CN100546637C (zh) | 一种治疗冠心病的中药组合物及其制备方法 | |
CN1686514A (zh) | 治疗焦虑症、抑郁症的中药制剂及其生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: XUANWU HOSPITAL OF CAPITAL UNIVERSITY OF MEDICAL Free format text: FORMER OWNER: GUANGZHOU SHIBAI MEDICINE SCIENCE + TECHNOLOGY CO., LTD. Effective date: 20061110 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20061110 Address after: 100053, 45, Zhen Li street, Xuanwu, Beijing Applicant after: XUANWU HOSPITAL CAPITAL MEDICAL University Address before: 510176 308A room, No. 36, Zhou Lu, Liwan District, Guangdong, Guangzhou, China Applicant before: Guangzhou Shibai Pharmaceutical Technology Co.,Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080409 Termination date: 20140123 |